NRX Pharmaceuticals Inc (NRXPW)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current NRXPW market cap is 15.59M. The company's latest EPS is USD -0.3482 and P/E is -9.36.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.81M | -4.41M | -6M | -7.05M | -3.02M |
| Net Income | -6.06M | -4.34M | -6.53M | -7.9M | -1.62M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 10.16M | 771k | 0 | 0 |
| Operating Income | -713k | -51.39M | -115.8M | -44.34M | -27.84M |
| Net Income | 408k | -51M | -348.89M | -39.75M | -30.16M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 13.11M | 7.32M | 3.79M | 5.26M | 4.46M |
| Total Liabilities | 19.33M | 19.05M | 18.86M | 23.66M | 23.28M |
| Total Equity | -6.22M | -11.73M | -15.07M | -18.39M | -18.82M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 32.08M | 2.94M | 32.73M | 25.82M | 7.32M |
| Total Liabilities | 2.58M | 46.72M | 11.92M | 18.41M | 19.05M |
| Total Equity | 5M | -43.78M | 20.81M | 7.41M | -11.73M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -18.47M | -21.66M | -3.67M | -6.23M | -8.54M |
| Investing | -4k | -3k | N/A | N/A | N/A |
| Financing | 7.32M | 6.2M | 395k | 3.54M | 5.59M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -793k | -2.27M | -37.7M | -39.76M | -21.66M |
| Investing | 40.25M | -1,000 | -7k | -10k | -3k |
| Financing | -39.47M | 3.25M | 63.46M | 32.21M | 6.2M |
| Market Cap | 15.59M |
| Price to Earnings Ratio | -9.36 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 61.39 |
| Price to Book Ratio | -24.06 |
| Dividend Yield | - |
| Shares Outstanding | 86.61M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.12 (40%) |
| Company Name | NRX Pharmaceuticals Inc |
| Address |
1201 orange st wilmington, delaware 19801 |
| Website | https://www.nrxpharma.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
